Free Trial

AQR Capital Management LLC Purchases 4,844 Shares of Houlihan Lokey, Inc. (NYSE:HLI)

Houlihan Lokey logo with Finance background

AQR Capital Management LLC lifted its stake in shares of Houlihan Lokey, Inc. (NYSE:HLI - Free Report) by 73.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,396 shares of the financial services provider's stock after purchasing an additional 4,844 shares during the quarter. AQR Capital Management LLC's holdings in Houlihan Lokey were worth $1,537,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Ameritas Investment Partners Inc. lifted its position in Houlihan Lokey by 0.5% in the 1st quarter. Ameritas Investment Partners Inc. now owns 18,293 shares of the financial services provider's stock valued at $2,345,000 after acquiring an additional 97 shares in the last quarter. Park Avenue Securities LLC lifted its position in Houlihan Lokey by 1.4% in the 2nd quarter. Park Avenue Securities LLC now owns 8,532 shares of the financial services provider's stock valued at $1,151,000 after acquiring an additional 120 shares in the last quarter. Portside Wealth Group LLC lifted its position in Houlihan Lokey by 6.3% in the 2nd quarter. Portside Wealth Group LLC now owns 2,224 shares of the financial services provider's stock valued at $300,000 after acquiring an additional 131 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. lifted its position in Houlihan Lokey by 27.7% in the 2nd quarter. Harel Insurance Investments & Financial Services Ltd. now owns 746 shares of the financial services provider's stock valued at $100,000 after acquiring an additional 162 shares in the last quarter. Finally, Crewe Advisors LLC increased its stake in Houlihan Lokey by 264.5% in the 2nd quarter. Crewe Advisors LLC now owns 226 shares of the financial services provider's stock valued at $30,000 after buying an additional 164 shares during the last quarter. Institutional investors own 78.07% of the company's stock.

Houlihan Lokey Trading Up 2.0 %

Shares of HLI stock traded up $3.28 during trading hours on Friday, hitting $167.48. 270,158 shares of the company were exchanged, compared to its average volume of 322,338. The firm has a fifty day simple moving average of $155.04 and a 200 day simple moving average of $141.24. Houlihan Lokey, Inc. has a 52-week low of $94.67 and a 52-week high of $167.87. The stock has a market capitalization of $11.64 billion, a price-to-earnings ratio of 37.14 and a beta of 0.66.

Houlihan Lokey (NYSE:HLI - Get Free Report) last issued its quarterly earnings results on Tuesday, July 30th. The financial services provider reported $1.22 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.22. Houlihan Lokey had a net margin of 15.30% and a return on equity of 18.80%. The company had revenue of $514.00 million during the quarter, compared to analyst estimates of $508.70 million. During the same quarter last year, the business posted $0.89 EPS. Houlihan Lokey's quarterly revenue was up 23.6% compared to the same quarter last year. Sell-side analysts anticipate that Houlihan Lokey, Inc. will post 5.64 EPS for the current year.

Houlihan Lokey Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Sunday, September 15th. Investors of record on Tuesday, September 3rd were paid a $0.57 dividend. The ex-dividend date was Tuesday, September 3rd. This represents a $2.28 dividend on an annualized basis and a yield of 1.36%. Houlihan Lokey's dividend payout ratio is 50.55%.

Insider Activity at Houlihan Lokey

In related news, General Counsel Christopher M. Crain sold 1,000 shares of Houlihan Lokey stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $155.29, for a total value of $155,290.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, Director Gillian Beth Zucker sold 200 shares of Houlihan Lokey stock in a transaction that occurred on Tuesday, August 20th. The shares were sold at an average price of $152.49, for a total value of $30,498.00. Following the completion of the transaction, the director now directly owns 7,001 shares in the company, valued at approximately $1,067,582.49. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, General Counsel Christopher M. Crain sold 1,000 shares of Houlihan Lokey stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $155.29, for a total transaction of $155,290.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 9,717 shares of company stock worth $1,479,513. Corporate insiders own 23.68% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have commented on HLI shares. Keefe, Bruyette & Woods reiterated a "market perform" rating and issued a $154.00 price objective (up previously from $139.00) on shares of Houlihan Lokey in a research note on Wednesday, July 31st. Morgan Stanley increased their price objective on shares of Houlihan Lokey from $146.00 to $163.00 and gave the company an "equal weight" rating in a research note on Monday, September 23rd. Wells Fargo & Company started coverage on shares of Houlihan Lokey in a research note on Thursday, September 12th. They issued an "underweight" rating and a $149.00 price objective for the company. JPMorgan Chase & Co. decreased their price objective on shares of Houlihan Lokey from $132.00 to $129.00 and set a "neutral" rating for the company in a research note on Wednesday, July 31st. Finally, UBS Group increased their price objective on shares of Houlihan Lokey from $170.00 to $190.00 and gave the company a "buy" rating in a research note on Tuesday. One investment analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, Houlihan Lokey currently has a consensus rating of "Hold" and an average price target of $157.00.

View Our Latest Analysis on HLI

Houlihan Lokey Company Profile

(Free Report)

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.

Featured Stories

Institutional Ownership by Quarter for Houlihan Lokey (NYSE:HLI)

→ Most People Are Dead Wrong. (From Brownstone Research) (Ad)

Should you invest $1,000 in Houlihan Lokey right now?

Before you consider Houlihan Lokey, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Houlihan Lokey wasn't on the list.

While Houlihan Lokey currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Strong Markets Meet Rising Volatility—Are Your Investments Safe?
Analysts Bullish on AI-Powered Healthcare: Intuitive Surgical’s 30% Upside
Oracle’s Cloud Shift Pays Off: Will Momentum Continue?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines